Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Tumor Immunotherapy01:27

Tumor Immunotherapy

2.1K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K
Cancer Vaccines01:30

Cancer Vaccines

1.2K
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.2K
The Tumor Microenvironment02:17

The Tumor Microenvironment

8.0K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
8.0K
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

7.8K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
7.8K
T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

16.9K
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
16.9K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

7.3K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.3K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Cell Simulation as Cell Segmentation.

bioRxiv : the preprint server for biology·2024
查看所有相关文章

相关实验视频

Updated: Mar 10, 2026

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

4.1K

将T细胞免疫的三个功能子集集成到癌症免疫治疗的综合模型中.

Jaeyoun Park1,2, Heeju Ryu1,2

  • 1Department of Immunology, School of Medicine, Sungkyunkwan University, Suwon 16419, Korea.

Immune network
|March 9, 2026
PubMed
概括

通过了解T细胞子集,可以改善癌症免疫疗法. 病毒特异性T细胞 (VSTs) 和旁观者T细胞与瘤特异性T细胞 (TASTs) 一起发挥关键作用,提供新的治疗策略.

科学领域:

  • 免疫学 免疫学 免疫学
  • 在瘤学瘤学.
  • 细胞生物学 细胞生物学

背景情况:

  • 目前的癌症免疫疗法主要使用瘤抗原特异性T细胞 (TASTs).
  • 检查点阻塞疗法虽然有效,但由于T细胞耗尽和低效的原始化等问题而面临局限性.
  • 瘤微环境是复杂的,通常含有更多的病毒特异性T细胞 (VST) 和旁观者T细胞,而不是TAST.

研究的目的:

  • 在瘤微环境中提出T细胞子集的综合模型.
  • 根据它们的起源和基因表达来描述这些子集.
  • 探索它们作为癌症免疫治疗中的生物标志物和治疗点的潜力.

主要方法:

  • 对高维单细胞数据的分析.
  • 通过本体生成和转录程序对T细胞子集的表征.
  • 在瘤中开发T细胞功能的综合模型.

主要成果:

  • 确定了三个功能性T细胞子集:经典的TAST,具有潜在TAST功能的VST和旁观者T细胞.
  • 证明VST可以通过病毒模拟作为TAST.
  • 强调了瘤免疫生态系统的异质性.
关键词:
收养细胞疗法采用细胞疗法.旁观者T细胞是什么?癌症免疫疗法癌症免疫疗法免疫检查点抑制剂 免疫检查点抑制剂瘤的Ag特异性T细胞特定于病毒的T细胞

更多相关视频

Monitoring the Cancer-Immunity Cycle and Exploring Tumor Microenvironment Dynamics
12:19

Monitoring the Cancer-Immunity Cycle and Exploring Tumor Microenvironment Dynamics

Published on: June 7, 2024

2.1K
Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells
09:04

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

1.8K

相关实验视频

Last Updated: Mar 10, 2026

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

4.1K
Monitoring the Cancer-Immunity Cycle and Exploring Tumor Microenvironment Dynamics
12:19

Monitoring the Cancer-Immunity Cycle and Exploring Tumor Microenvironment Dynamics

Published on: June 7, 2024

2.1K
Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells
09:04

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

1.8K

结论:

  • 这些T细胞子集可以作为免疫治疗反应的预测生物标志物.
  • 对于每个子组,可以制定不同的治疗策略,包括采用细胞移植.
  • 这种模型有助于理解感冒瘤的耐药性,并指导新的治疗方法.